This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bristol-Myers Squibb Compnay, Pfizer Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2024
Title: The Innovations of Daniel Kuntz
Introduction
Daniel Kuntz is an accomplished inventor based in Bend, Oregon. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for apixaban, a medication used to treat thromboembolic disorders. His innovative work has led to the granting of a patent, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Daniel Kuntz holds a patent for apixaban formulations. This patent provides a pharmaceutical formulation of apixaban, which is crucial for its application in treating thromboembolic disorders. His work in this area highlights the importance of effective medication formulations in improving patient outcomes.
Career Highlights
Throughout his career, Daniel Kuntz has worked with prominent companies in the pharmaceutical industry. He has been associated with Bristol-Myers Squibb Company and Pfizer Corporation, where he has contributed to various projects and initiatives aimed at enhancing drug development and delivery.
Collaborations
Daniel has collaborated with notable professionals in his field, including Sherif Ibrahim Farag Badawy and Timothy D. Stevens. These collaborations have further enriched his work and have played a role in the successful development of his patented formulations.
Conclusion
In summary, Daniel Kuntz is a notable inventor whose work in apixaban formulations has made a significant impact in the pharmaceutical industry. His collaborations and career experiences reflect his commitment to innovation and excellence in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile